Total Liabilities for Merck & Co. (MRK)
According to Merck & Co.'s latest reported financial statements, the company's latest reported total liabilities is $84.20B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

MRK
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$84.20B
YoY change
+19.0%
5Y CAGR
+4.9%
Peak year (2025)
$84.20B
Latest annual
$84.20B
Total Liabilities history chart for Merck & Co. (MRK) from 1985 to 2025
Total Liabilities history table for Merck & Co. (MRK) from 1985 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $84.20B | +19.0% | ||
| 2024 | $70.73B | +2.5% | ||
| 2023 | $69.04B | +9.4% | ||
| 2022 | $63.10B | -6.4% | ||
| 2021 | $67.44B | +1.9% | ||
| 2020 | $66.18B | +13.3% | ||
| 2019 | $58.40B | +4.7% | ||
| 2018 | $55.76B | +4.6% | ||
| 2017 | $53.30B | -3.2% | ||
| 2016 | $55.07B | -3.2% | ||
| 2015 | $56.91B | +15.3% | ||
| 2014 | $49.38B | -7.4% | ||
| 2013 | $53.32B | +5.2% | ||
| 2012 | $50.67B | +5.2% | ||
| 2011 | $48.19B | -1.6% | ||
| 2010 | $48.98B | -3.6% | ||
| 2009 | $50.83B | +95.3% | ||
| 2008 | $26.03B | -6.2% | ||
| 2007 | $27.76B | +12.8% | ||
| 2006 | $24.60B | +0.6% | ||
| 2005 | $24.46B | +6.9% | ||
| 2004 | $22.88B | +8.4% | ||
| 2003 | $21.10B | -13.7% | ||
| 2002 | $24.43B | +5.6% | ||
| 2001 | $23.13B | +15.3% | ||
| 2000 | $20.06B | +5.9% | ||
| 1999 | $18.93B | +23.4% | ||
| 1998 | $15.35B | +28.2% | ||
| 1997 | $11.98B | +19.6% | ||
| 1996 | $10.01B | +2.1% | ||
| 1995 | $9.81B | +3.2% | ||
| 1994 | $9.51B | +8.5% | ||
| 1993 | $8.76B | +60.6% | ||
| 1992 | $5.46B | +36.8% | ||
| 1991 | $3.99B | +9.4% | ||
| 1990 | $3.65B | +33.7% | ||
| 1989 | $2.73B | -16.7% | ||
| 1988 | $3.27B | -8.2% | ||
| 1987 | $3.56B | +40.5% | ||
| 1986 | $2.54B | +11.8% | ||
| 1985 | $2.27B | — |
Total Liabilities values are taken from Merck & Co.'s reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Merck & Co. (MRK) reported total liabilities of $84.20B – grew 19.0% year-over-year.
Through 2020–2025 (5 years), Merck & Co. total liabilities delivered a +4.9% annualised rate; with the latest reading among the more recent periods of the dataset.
The dataset's maximum total liabilities sits at $84.20B (2025); the minimum reading of $2.27B dates to 1985.
Among 8 Healthcare peers, Merck & Co. (MRK) ranks 6th; the peer median for total liabilities is $101.80B.
Merck & Co. Total Liabilities by Year
Merck & Co. Total Liabilities 2025: $84.20B
Merck & Co. total liabilities in 2025 was $84.20B, grew 19.0% from 2024. This figure represents the highest annual value in the available history.
Merck & Co. Total Liabilities 2024: $70.73B
Merck & Co. total liabilities in 2024 was $70.73B, edged up 2.5% from 2023.
Merck & Co. Total Liabilities 2023: $69.04B
Merck & Co. total liabilities in 2023 was $69.04B, grew 9.4% from 2022.
Merck & Co. Total Liabilities 2022: $63.10B
Merck & Co. total liabilities in 2022 was $63.10B, declined 6.4% below 2021.
Merck & Co. Total Liabilities 2021: $67.44B
Merck & Co. total liabilities in 2021 was $67.44B.
See more financial history for Merck & Co. (MRK).
Sector peers — Total Liabilities
Companies in the same sector as Merck & Co., ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $56.81B | Healthcare |
Frequently asked questions
What is Merck & Co.'s total liabilities?
- Latest reported total liabilities for Merck & Co. (MRK) is $84.20B (period ending December 31, 2025).
How has Merck & Co. total liabilities changed year-over-year?
- Merck & Co. (MRK) total liabilities changed +19.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Merck & Co. total liabilities?
- Merck & Co. (MRK) total liabilities compound annual growth rate is +4.9% over the most recent 5 years available.
When did Merck & Co. total liabilities hit its highest annual value?
- Merck & Co. total liabilities reached its highest annual value of $84.20B in 2025.
What was Merck & Co. total liabilities in 2024?
- Merck & Co. (MRK) total liabilities in 2024 was $70.73B.
What was Merck & Co. total liabilities in 2025?
- Merck & Co. (MRK) total liabilities in 2025 was $84.20B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRK Overview
Company profile, financial tools, and key metrics
MRK Revenue Counter
Earns $2,061 every second. See per minute, hour, and day.
MRK Earnings Counter
Earns $578.83 per second net profit. See per minute, hour, and day.
MRK Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
MRK What If Invested
What if you had invested $1,000? See historical returns from any date.
MRK How It Makes Money
Discover visual breakdown of $65.01B in revenue — where it comes from and where it goes.
MRK Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRK Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRK Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
MRK Buybacks
2.39% TTM buyback yield. Shareholder yield & SBC comparison.
MRK Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
MRK Dividend Profile
Yield: 2.99%. Safety: 8/8. See full history.
MRK Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
MRK Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.